Publication & Citation Trends
Publications
0 total
Refining Risk Assessment for Adjuvant CDK4/6 Inhibitors beyond Trial Inclusion Criteria: Integrating Recurrence Score and Endocrine Responsiveness according to ADAPT.
Cited by 0
Semantic Scholar
Neoadjuvante Therapie – Chancen der Therapieoptimierung
Cited by 0
Semantic Scholar
HER2-low status as a distinct breast cancer subtype: myth or truth? Analysis of the WSG trials WSG-ADAPT-HR+/HER2-, WSG-PlanB, and WSG-ADAPT-TN
Cited by 4
Semantic Scholar
Multimodal Artificial Intelligence Model From Baseline Histopathology Adds Prognostic Information for Distant Recurrence Assessment in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer.
Cited by 0
Semantic Scholar
Patient outcomes in WSG-ADAPT according to NATALEE and MonarchE risk criteria.
Cited by 0
Semantic Scholar
Endocrine response assessment in HR-positive HER2-negative early breast cancer: concordance of local versus central Ki67 measurements in the WSG ADAPTcycle trial (n = 5292)
Cited by 1
Semantic Scholar
A predictive endocrine resistance index accurately stratifies luminal breast cancer treatment responders and nonresponders
Cited by 2
Semantic Scholar
Genetic Alterations, Therapy Response, and Survival Among Patients With Triple-Negative Breast Cancer OA
Cited by 5
Semantic Scholar
Research Topics
Breast Cancer Treatment Studies
(37)
HER2/EGFR in Cancer Research
(21)
Advanced Breast Cancer Therapies
(19)
BRCA gene mutations in cancer
(18)
Molecular Biology Techniques and Applications
(13)
Affiliations
University Medical Center Groningen
Institute of Cancer Research
Radboud University Nijmegen
Witten/Herdecke University
Universität Hamburg